Eli Lilly will partner with Nimbus Therapeutics to develop an oral treatment for obesity and other metabolic diseases, through a multi-year research collaboration and exclusive worldwide license ...

Shares of Ventyx Biosciences gained after The Wall Street Journal reported that the company is in advanced talks to be acquired by Eli Lilly for about $1 billion. Ventyx shares were up 5.2%, to $8.23, ...

Nimbus Therapeutics announced it has entered into a multi-year research collaboration and $1.3 exclusive license agreement ...

Nimbus and Eli Lilly collaborate to develop an oral treatment for obesity, leveraging computational chemistry and structure-based drug design. Nimbus Therapeutics and Eli Lilly announce their ...

Dow Jones Top Company Headlines at 1 PM ET: Eli Lilly, Nimbus Partner to Develop, License Oral Obesity Treatment | AIG ... Eli Lilly and Nimbus Therapeutics have entered into a multiyear collaboration ...

Lilly has seen dramatic sales growth over the last couple of years from its injectable, dual GLP-1/GIP agonist obesity ...

Eli Lilly has returned to Nimbus Therapeutics for another metabolic collaboration, this time focused on the red-hot R&D space ...

Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a drug discovery company developing breakthrough medicines through its AI-enhanced computational drug discovery engine, today announced it ...

Mysterious cat Nimbus Pronos has tipped Nigeria to beat Mozambique in their AFCON 2025 Round of 16 clash, boosting confidence ...

Nimbus Pronos, the cat oracle, predicts the Super Eagles to defeat Mozambique in their 2025 Africa Cup of Nations Round of 16 ...

More snow is expected to fall across north-east England as a spell of cold weather continues into the new week. The Met ...